Oliver Wyman Announces New Season of Health Podcast

Jun 28, 2018

Chicago -- Oliver Wyman announced today the launch of a new season of the Oliver Wyman Health Podcast. Led by four Partners in Oliver Wyman’s Health & Life Sciences division – Sam Glick, Helen Leis, Tom Robinson, and Jim Fields – the Oliver Wyman Health Podcast explores the business of transforming healthcare and features executive conversations with senior healthcare influencers and leaders. Topics for upcoming episodes include: unexpected partnerships (such as Comcast-Independence Blue Cross), artificial intelligence, robotics, cybersecurity, aging and end-of-life care, the opioid crisis, reducing unnecessary care, women’s health, executive leadership, and social determinants, among other key issues.

Says Sam Glick, “At Oliver Wyman, we have the privilege of working with some of the world’s most innovative and most influential healthcare organizations. Through the Oliver Wyman Health Podcast, we get to extend our conversations beyond the boardroom to engage a broader audience.”

New podcast episodes include: 

Comcast NBCUniversal and Independence Blue Cross Discuss PartnershipIndependence Health Group and Comcast announced a unique partnership to create an innovative patient-centered technology and communications platform. Here, Helen Leis sits down with Brian Lobley, President of Commercial and Consumer Markets at Independence Blue Cross, and Don Mathis, General Manager of Growth at Comcast NBCUniversal, to discuss why two companies from such different ends of the spectrum came together, and what it’s like bringing a healthcare insider and outsider together as one.

Interactive Robot Sparks Consumer Dialog on Chronic Conditions Dr. Cory Kidd, Founder and Chief Executive Officer of Catalia Health, who holds a PhD in human-robot interaction from the MIT Media Lab, discusses how robotics and artificial intelligence are advancing aging and chronic disease management. Cory shares with host Sam Glick, how Catalia Health is solving real world healthcare challenges with interactive technologies.

Wearables, Ingestibles, and (the Inevitable) Cyberattack 

Cybercriminals in healthcare are stealthy. From being able to turn off someone’s pacemaker without warning, to secretly changing someone’s prescription dosage without a pharmacist’s knowledge, cyberattacks can be devastating for health consumers. Here, Sam Hanna, Professor of Healthcare Management, Policy, and Strategy at George Washington University, and former Chief HIPAA Security and Privacy Officer at the Dana Farber Cancer Institute, chats with Sam Glick about how protecting patient information will advance patient care.

Using Machine Learning to Predict Chance of Death

Jeremy Powell, Chief Executive Officer of Acclivity Health, chats with Helen Leis about how his company's machine learning/deep learning solution is helping physicians deliver appropriate palliative care. Jeremy shares some of his top solutions for better care delivery and explains what’s being done to ensure patients die on their own terms.

What Would Copernicus Do? Insights from Health Evolution 

Julie Murchinson, Chief Executive Officer of Health Evolution, examines how healthcare leaders’ perceptions are shifting away from the status quo, and discusses why healthcare’s ongoing transformation parallels Copernican Theory where unconventional thinking triggered an avalanche of innovative discovery. She also discusses how to build a community of leaders that drives the industry forward and accelerates change.

Other podcast episodes coming later this year, as well as a few of our most popular past episodes, include:

  • Reimagining Population Health – The transition to value-based payment models has advanced an entire industry centered on population health. As these programs continue to expand, the industry has reached an inflection point where executing on a next generation population health model is essential. In this podcast, Dr. David Nash, Dean of the Jefferson College of Population Health, and Dr. Stuart Baker, Executive Officer and President of Navvis, discuss the importance of reimagining population health for a new generation, and how academic research and rigor will benefit the entire industry.
  • (The Consumer And) Payer-Provider Partnerships – Niyum Gandhi, Executive Vice President and Chief Population Health Officer, Mount Sinai Health System, discusses how healthcare organizations can best collaborate to provide consumers with a truly seamless experience, and shares his own experiences of what makes a joint venture truly flourish.
  • How AI Turns Data into Patient Satisfaction – Mudit Garg, Founder and Chief Executive Officer, Qventus, talks about how artificial intelligence and machine learning are streamlining hospital operations to turn messy, convoluted masses of EMR data into actionable decisions that lead to happier healthcare consumers.
  • What is the “Right” Medical Decision? – Dr. Marty Makary, Professor of Surgery, and Health Policy and Management, Johns Hopkins Medicine, and Practicing WiselyTM Advisor, and Dr. John Albertini, Co-founder of The Skin Surgery Center / QualDerm Partners, and former President of the American College of Mohs Surgery discuss with Jim Fields how a new class of quality measures, which evaluate variation in physician medical practice, can save lives and advance appropriate care delivery.
  • Examining the Inner Workings of the Castlight / Jiff Partnership – John Doyle, Castlight’s Chief Executive Officer, and Derek Newell, Castlight’s President, discuss the greater implications of Castlight and Jiff’s strategic merger, and how Castlight is pushing the evolution of health benefit solutions.
  • What is Blockchain Anyway and How Will It Transform Healthcare? – Chris Kay, Senior Vice President and Chief Innovation Officer, Humana, chats about Blockchain 101 and its deployment in healthcare and outlines a how-to solution to incumbent-innovator collaboration.
  • Aetna’s Unique Strategy for Payer-Provider Partnerships – Brigitte Nettesheim, President of Transformative Markets, Aetna, shares with Tom Robinson the insurer’s strategy for payer-provider partnerships and explains what makes these joint ventures different from earlier generations of partnerships.
  • Managing Chronic Disease with Coaching and Technology – Glen Tullman, Chairman and Chief Executive Officer, Livongo Health, discusses how the health system has failed at chronic disease management, how cloud technology can transform chronic disease management, how coaching needs to be contextually relevant and non-intrusive, and what the future of healthcare looks like.

To learn more about new episodes of the Oliver Wyman Health podcast, see our podcast page and subscribe on iTunes. For more information on each episode, visit health.oliverwyman.com.

For more information, please contact our podcast producer:

Jacqueline DiChiara, Editor, Oliver Wyman



Oliver Wyman’s Health & Life Sciences Practice

Oliver Wyman’s Health & Life Sciences practice serves clients in the pharmaceutical, biotechnology, medical devices, provider, and payer sectors with strategic, operational, and organizational advice. Deep healthcare knowledge and capabilities allow the practice to deliver fact-based solutions.

Oliver Wyman launched the Health Innovation Center (OWHIC) in 2011 to promote positive change in healthcare. OWHIC champions innovation by disseminating proven innovations; envisioning market-based solutions to today’s and tomorrow’s challenges; and establishing a cross-industry community of thought-leaders to share and shape ideas. For the latest on the business of transforming healthcare, visit Oliver Wyman Health digital platform at health.oliverwyman.com.


Oliver Wyman

Oliver Wyman is a global leader in management consulting. With offices in 50+ cities across nearly 30 countries, Oliver Wyman combines deep industry knowledge with specialized expertise in strategy, operations, risk management, and organization transformation. The firm has more than 4,700 professionals around the world who help clients optimize their business, improve their operations and risk profile, and accelerate their organizational performance to seize the most attractive opportunities. Oliver Wyman is a wholly owned subsidiary of Marsh & McLennan Companies [NYSE: MMC]. For more information, visit www.oliverwyman.com. Follow Oliver Wyman on Twitter @OliverWyman.